瑞典全国研究:皮肤银屑病与躯体共病同精神疾病发生的关联
该回顾性匹配病例对照研究基于瑞典2005–2010年注册数据,纳入93 239例皮肤银屑病患者与1 387 495名对照。相比无银屑病及无躯体共病者,无躯体共病的银屑病患者精神疾病发生风险高1.32倍,合并躯体共病者高2.56倍,未发现协同作用。
要点
- 银屑病不伴躯体共病时精神疾病风险HR 1.32(95%CI 1.27-1.36)。
- 银屑病伴躯体共病时精神疾病风险HR 2.56(95%CI 2.46-2.66)。
核心结论
- 躯体共病对精神疾病发生的影响似乎甚至大于皮肤银屑病本身。
- 皮肤银屑病与躯体共病同精神疾病发生的关联支持对银屑病患者采取积极、整体的治疗。
研究设计与样本
- 回顾性匹配病例对照研究,使用瑞典常规临床诊疗的行政人口注册数据。
- 纳入93 239例皮肤银屑病患者(平均[SD]年龄54[17]岁;47 475名男性[51%])和1 387 495名对照(平均[SD]年龄54[16]岁;702 332名男性[51%]),按年龄、性别和市镇匹配,均无既往精神疾病。
主要发现
- 银屑病患者较对照更常合并躯体共病和精神疾病。
- 相比无银屑病且无躯体共病者,无躯体共病的银屑病患者精神疾病发生风险HR 1.32(95%CI 1.27-1.36;P<.001)。
- 相比无银屑病且无躯体共病者,合并躯体共病的银屑病患者精神疾病发生风险HR 2.56(95%CI 2.46-2.66;P<.001)。
- 未发现皮肤银屑病与躯体共病对精神疾病发生的协同关联(HR 0.93;95%CI 0.81-1.04;P=.21)。
关键数值与推荐
- 暴露包括皮肤银屑病及躯体共病(通过Charlson共病指数和Elixhauser共病指数捕获)。
- 主要结局为精神疾病发生,即抑郁、焦虑和自杀倾向的复合终点,并分别评估三个组分。
- 使用Kaplan-Meier曲线按银屑病和躯体共病分层展示风险,采用Cox比例风险回归分析调整关联并纳入交互项评估协同作用。
临床怎么用
- 对银屑病患者应积极评估和管理躯体共病,因其与精神疾病风险升高相关。
- 银屑病治疗需采取整体策略,关注精神健康。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Psoriasis is a complex systemic disease with skin involvement, somatic comorbidity, and psychiatric illness (PI). Although this view of psoriasis is widely accepted, potential synergies within this triad of symptoms have not been adequately investigated. OBJECTIVES: To investigate the independent association of skin psoriasis and somatic comorbidity with the development of PI and to assess whether skin psoriasis and somatic comorbidity act synergistically to produce a risk of PI that is greater than the additive associations. DESIGN, SETTING, AND PARTICIPANTS: Participants were enrolled between January 2005 and December 2010, in this retrospective matched case-control study using secondary (ie, administrative), population-based registry data from Swedish patients in routine clinical care. The dates of analysis were March 2017 to December 2019. Participants were patients with skin psoriasis and control participants without psoriasis matched on age, sex, and municipality, who were all free of preexisting PI. EXPOSURES: Presence of skin psoriasis and somatic comorbidity (captured through the Charlson Comorbidity Index and the Elixhauser Comorbidity Index). MAIN OUTCOMES AND MEASURES: Risk of PI onset (composite of depression, anxiety, and suicidality) is shown using Kaplan-Meier curves stratified by the presence of skin psoriasis and somatic comorbidity. Adjusted associations of skin psoriasis and somatic comorbidity with the development of PI were analyzed using Cox proportional hazards regression models, including interactions to assess synergistic associations. The 3 components of PI were also assessed individually. RESULTS: A total of 93 239 patients with skin psoriasis (mean [SD] age, 54 [17] years; 47 475 men [51%]) and 1 387 495 control participants (mean [SD] age, 54 [16] years; 702 332 men [51%]) were included in the study. As expected, patients with skin psoriasis were more likely to have somatic comorbidity and PI than control participants. Compared with those without skin psoriasis or somatic comorbidity, patients with psoriasis without somatic comorbidity had a 1.32 times higher risk of PI onset (hazard ratio [HR], 1.32; 95% CI, 1.27-1.36; P < .001), whereas patients with psoriasis with somatic comorbidity had a 2.56 times higher risk of PI onset (HR, 2.56; 95% CI, 2.46-2.66; P < .001). No synergistic associations of skin psoriasis and somatic comorbidity with the development of PI were found (HR, 0.93; 95% CI, 0.81-1.04; P = .21). CONCLUSIONS AND RELEVANCE: This study found that somatic comorbidity appeared to alter PI onset even more than skin psoriasis. The observed association of skin psoriasis and somatic comorbidity with the development of PI reinforces the need for proactive, holistic treatment of patients with psoriasis.
引用
- Geale K, Henriksson M, Jokinen J, et al. Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study. JAMA Dermatol. 2020. PMID: 32492085. doi:10.1001/jamadermatol.2020.1398
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。